Hospital News and Research

RSS

Study compares minimally invasive and open surgeries for lower back pain

Rush University Medical Center is assessing whether minimally invasive surgery to relieve lower back pain differs from open surgery in terms of complication rate, recovery time, outcome and cost.

13 Oct 2010

New, longer lasting LVAD implanted in Canadian heart-failure patient

In a Canadian first, the Peter Munk Cardiac Centre used a new kind of left ventricular assist device (LVAD) to treat a patient with advanced heart failure. The new device is longer lasting than older generation LVADs and may eliminate the need for a second LVAD - a major drawback with the old technology.

13 Oct 2010

Gene Biodesign joins Roche NimbleGen Certified Service Provider Program

Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

13 Oct 2010

Study confirms increase in liability costs for hospitals and physicians

Hospitals and physicians should prepare for increasing liability costs, according to the 2010 Hospital Professional Liability and Physician Liability Benchmark Analysis created by Aon Risk Solutions, the global risk management business of Aon Corporation, in conjunction with the American Society for Healthcare Risk Management.

13 Oct 2010

SNM and SPR approve new North American Guidelines for Radiopharmaceutical Doses for Children

The Society of Nuclear Medicine (SNM) and the Society for Pediatric Radiology's Board of Directors recently approved new North American Guidelines for Radiopharmaceutical Doses for Children. These societies have expanded their pediatric radiation protection initiative by standardizing doses (based on body weight) for 11 nuclear medicine procedures commonly performed in children. The Alliance for Radiation Safety in Pediatric Imaging has collaborated in this effort, and will support efforts to promote the new, lower radiopharmaceutical doses.

13 Oct 2010

Commercial genetic profiling services should provide detailed information about test results: Report

Direct-to-consumer personal genetic profiling services that claim to predict people's health risks by analysing their DNA are often inconclusive and companies that sell them should provide better information about the evidence on which the results are based, says the UK Nuffield Council on Bioethics, in a new report on the ethics of so-called personalised healthcare services.

13 Oct 2010

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, today announced publication of results from a Phase III, long-term safety, tolerability and consistency of effect, clinical study of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).

13 Oct 2010

New cancer initiative may promote rapid drug development

Greenville Hospital System University Medical Center (GHS) unveiled details of its new Institute for Translational Oncology Research, a visionary cancer initiative that will help pave the way for new breakthroughs in rapid drug development, diagnostic discovery and advanced cancer care. ITOR is part of the GHS Cancer Center, a recognized regional multi-disciplinary center.

13 Oct 2010

New evidence supports possible link between XMRV and prostate cancer

Xenotropic murine leukemia virus-related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection.

13 Oct 2010

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

Donor kidneys can be successfully transplanted even if there is strong tissue incompatibility between donor and recipient. An interdisciplinary working group headed by Dr. Christian Morath, senior consultant at the Department of Nephrology at Heidelberg University Hospital (Medical Director: Professor Dr. Martin Zeier) and Professor Dr. Caner S-sal, head of antibody laboratory in the Department of Transplantation Immunology, showed in a study of 34 sensitized high-risk patients that the success rate in these patients was not different from the success rate of patients with a low immunological risk.

13 Oct 2010

CyDex terminates joint development agreement on Captisol-enabled clopidogrel with Prism Pharmaceuticals

CyDex Pharmaceuticals, Inc. today announced a mutual decision with Prism Pharmaceuticals to terminate their existing joint development agreement on novel Captisol-enabled® intravenous formulations of clopidogrel. This provides CyDex with full development and commercialization rights to the product candidate - an injectable formulation of clopidogrel. Clopidogrel is the active ingredient in PLAVIX®, an orally available antiplatelet drug, which currently is marketed by Bristol-Myers Squibb Company and Sanofi-Aventis, Inc.

13 Oct 2010

NHC enter agreement with Attain to offer new program for IVF fertility treatments

IntegraMed America, Inc. the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced that its Attain Fertility Centers division has entered into an agreement with The New Hope Center for Reproductive Medicine (NHC) to begin offering the Attain IVF family of specialty financing Programs.

13 Oct 2010

Investigators wondering: Fraud, bad medicine or Union manuevering at Calif. hospital chain?

The Los Angeles Times reports that state and federal investigators are trying to determine whether "a serious health problem or multimillion-dollar Medicare fraud" is behind a reported spike in blood poisoning cases at hospitals operated by Prime Healthcare Services, "a Southern California hospital chain known for aggressive billing practices and cost-cutting."

13 Oct 2010

Redesigned version of CTC-Chip effective in capturing rare circulating tumor cells

A redesigned version of the CTC-Chip a microchip-based device for capturing rare circulating tumor cells (CTCs) appears to be more effective and should be easier to manufacture than the original. Called the HB-(herringbone) Chip, the new device also may provide more comprehensive and easily accessible data from captured tumor cells.

13 Oct 2010

Vocera acquires Clinical Health Communications and Integrated Voice Solutions

Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.

13 Oct 2010

Stanford medical school doctor, author teaches 'The art of the physicial'

The New York Times profiles physician, professor and author Dr. Abraham Verghese: "At Stanford, he is on a mission to bring back something he considers a lost art: the physical exam. The old-fashioned touching, looking and listening — the once prized, almost magical skills of the doctor who missed nothing and could swiftly diagnose a peculiar walk, sluggish thyroid or leaky heart valve using just keen eyes, practiced hands and a stethoscope.

13 Oct 2010

Akonni receives NIJ grant to develop HCID system for SNP identification

Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated genetic testing devices for diagnosing complex infectious and human diseases, today announced receipt of a nearly $500,000 Phase III Grant from the National Institutes of Justice (NIJ).

13 Oct 2010

Scientists design synthetic molecule to protect liver cancer cells from toxic effects of chemotherapy

Scientists have found that a synthetic molecule they designed can block activation of a gene in liver cancer cells, halting a process that allows some of those cancer cells to survive chemotherapy.

13 Oct 2010

Researchers find gene association between Type 2 diabetes and Alzheimer's disease progression

Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease. The research, led by Giulio Maria Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry and Geriatrics and Adult Development at Mount Sinai School of Medicine, was published this month in Aging Cell.

13 Oct 2010

HSV1716 clinical trial for childhood cancer receives FDA grant

A clinical trial testing a genetically reprogrammed herpes simplex virus as treatment for deadly forms of childhood cancer has received a U.S. Food and Drug Administration grant to support the research.

13 Oct 2010

Hospital News and Research

Study compares minimally invasive and open surgeries for lower back pain

New, longer lasting LVAD implanted in Canadian heart-failure patient

Gene Biodesign joins Roche NimbleGen Certified Service Provider Program

Study confirms increase in liability costs for hospitals and physicians

SNM and SPR approve new North American Guidelines for Radiopharmaceutical Doses for Children

Commercial genetic profiling services should provide detailed information about test results: Report

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

New cancer initiative may promote rapid drug development

New evidence supports possible link between XMRV and prostate cancer

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

CyDex terminates joint development agreement on Captisol-enabled clopidogrel with Prism Pharmaceuticals

NHC enter agreement with Attain to offer new program for IVF fertility treatments

Investigators wondering: Fraud, bad medicine or Union manuevering at Calif. hospital chain?

Redesigned version of CTC-Chip effective in capturing rare circulating tumor cells

Vocera acquires Clinical Health Communications and Integrated Voice Solutions

Stanford medical school doctor, author teaches 'The art of the physicial'

Akonni receives NIJ grant to develop HCID system for SNP identification

Scientists design synthetic molecule to protect liver cancer cells from toxic effects of chemotherapy

Researchers find gene association between Type 2 diabetes and Alzheimer's disease progression

HSV1716 clinical trial for childhood cancer receives FDA grant

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News